S

ST Pharm Co Ltd
KOSDAQ:237690

Watchlist Manager
ST Pharm Co Ltd
KOSDAQ:237690
Watchlist
Price: 94 900 KRW 0.74% Market Closed
Market Cap: 1.9T KRW
Have any thoughts about
ST Pharm Co Ltd?
Write Note

ST Pharm Co Ltd
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

ST Pharm Co Ltd
Total Equity Peer Comparison

Comparables:
207940
F
220100
L
141080
C
268600
E
456070

Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
S
ST Pharm Co Ltd
KOSDAQ:237690
Total Equity
â‚©384.6B
CAGR 3-Years
9%
CAGR 5-Years
4%
CAGR 10-Years
N/A
Samsung Biologics Co Ltd
KRX:207940
Total Equity
â‚©10.3T
CAGR 3-Years
29%
CAGR 5-Years
20%
CAGR 10-Years
N/A
F
FutureChem Co Ltd
KOSDAQ:220100
Total Equity
â‚©58.5B
CAGR 3-Years
1%
CAGR 5-Years
32%
CAGR 10-Years
N/A
L
LegoChem Biosciences Inc
KOSDAQ:141080
Total Equity
â‚©148.2B
CAGR 3-Years
21%
CAGR 5-Years
8%
CAGR 10-Years
26%
C
Cellivery Therapeutics Inc
KOSDAQ:268600
Total Equity
-â‚©27.2B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
E
ENCell Co Ltd
KOSDAQ:456070
Total Equity
â‚©38B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is ST Pharm Co Ltd's Total Equity?
Total Equity
384.6B KRW

Based on the financial report for Jun 30, 2024, ST Pharm Co Ltd's Total Equity amounts to 384.6B KRW.

What is ST Pharm Co Ltd's Total Equity growth rate?
Total Equity CAGR 5Y
4%

Over the last year, the Total Equity growth was 14%. The average annual Total Equity growth rates for ST Pharm Co Ltd have been 9% over the past three years , 4% over the past five years .

Back to Top